CU Innovations Announces New Biomedical Technology Commercialization Program

Estimated read time 2 min read

[November 29, 2023] – CU Innovations, the technology transfer office for the University of Colorado Anschutz Medical Campus and the University of Colorado Denver, has announced a new biomedical technology commercialization program. The program will provide funding, mentorship, and other resources to help researchers commercialize their inventions.

Foresight Diagnostics Receives Grant from Colorado BioScience Association

[November 29, 2023] – Foresight Diagnostics, a Colorado-based startup that is developing a novel liquid biopsy testing platform for the measurement of minimal residual disease (MRD), has received a grant from the Colorado BioScience Association (CBSA). The grant will be used to support the development of the company’s technology.

CU Innovations Partners with Industry to Develop New Medical Devices

[November 29, 2023] – CU Innovations has partnered with several industry partners to develop new medical devices. The partnerships will bring together the expertise of CU researchers and industry partners to develop new technologies that will improve patient care.

CU Innovations Announces New Director of Business Development & Licensing

[November 29, 2023] – CU Innovations has announced the appointment of Michael McGarry as Director of Business Development & Licensing. McGarry will be responsible for leading the office’s efforts to commercialize technology and develop ventures.

CU Innovations Wins Award for Best Technology Transfer Office in Colorado

[November 29, 2023] – CU Innovations has been named the Best Technology Transfer Office in Colorado by the Association of University Technology Managers (AUTM). The award is based on the office’s performance in a number of areas, including the number of licenses executed, the amount of revenue generated from licensing, and the number of startups created.

+ There are no comments

Add yours